MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    monogenic parkinsonism in latin america: systematic review and meta-analysis

    P. Saffie-Awad, D. Texeira, P. Chana-Cuevas, A. Schumacher-Schuh (Santiago, Chile)

    Objective: This study aims to assess the frequency, distribution and the minimum prevalence of monogenic Parkinsonism in Latin America (LA) Background: The prevalence of monogenic…
  • 2023 International Congress

    Stiff-person syndrome associated with anti-Yo1 antibodies: a case report

    E. Chekanova, I. Luneva, A. Kozlova, O. Smetanina, M. Zakharova (Moscow, Russian Federation)

    Objective: To present an unusual presentation of paraneoplastic stiff-person syndrome (SPS). Background: SPS may have paraneoplastic, autoimmune, or cryptogenic etiology and most often be associated…
  • 2023 International Congress

    Clinical Phenotypes and Imaging Localization of Movement Disorders after Acute Stroke

    E. Samra, T. Roushdy, A. Saeed, A. Mansour, A. Elbassiouny, A. Shalash (Kafr Elsheikh, Egypt)

    Objective: Objective: The aim of this study was to identify MD in a sample of acute stroke patients and to determine their frequency, clinical characteristics,…
  • 2023 International Congress

    Effects of physical exercise interventions on cognitive function in Parkinson’s disease: an updated systematic review and meta-analysis of randomized controlled trials

    R. Kim, JS. Jun, N. Kang (Incheon, Republic of Korea)

    Objective: To determine whether physical exercise interventions can improve cognitive function, including overall performance and specific domains, in patients with Parkinson’s disease (PD) and to…
  • 2023 International Congress

    Alzheimer’s Disease Co-pathology and its Influence on Biofluid Biomarkers in Autopsied Subjects from the PPMI Study

    D. Coughlin, K. Hwang, E. Bayram, D. Galasko (San Diego, USA)

    Objective: To examine the relationship between biofluid biomarkers and post-mortem pathological findings in autopsied subjects from the Parkinson’s Progression Marker Initiative (PPMI). Background: The PPMI…
  • 2023 International Congress

    Familial Parkinson’s: Epidemiological data at Blida University Hospital.

    M. Benmahdjoub, K. Kesraoui, S. Bouchetara, M. Arezki (Blida, Algeria)

    Objective: In Algeria, few epidemiological data published on PD. The objective of this work is to study the epidemiological aspects of familial parkinson (PF) at…
  • 2023 International Congress

    Evaluation of Cognitive Assessment Tools in Parkinson’s Disease

    L. Cao, Y. Huang (Beijing, China)

    Objective: To evaluate a variety of cognitive assessment scales in a longitudinal Parkinson’s disease (PD) cohort. Background: Cognitive impairment is one of the most common and…
  • 2023 International Congress

    Consanguinity is the key player in complexity of Mendelian form of neurodegeneration with brain iron accumulation in Pakistan

    SHB. Rehman (Bannu, Pakistan)

    Objective: In the current work, we recognized big inbreed Pakistani family with autosomal recessive NBIA containing several affected individuals. Aim of the research work was…
  • 2023 International Congress

    Estrogen and progesterone influence membrane functions and glucose transporter expression in synaptosomes of different age groups of naturally menopausal rats

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The objective of this study was to determine the effect of 17 β-estradiol (E2) and progesterone (P4) on the activities of Na+ K+ ATPase, monoamine…
  • 2023 International Congress

    The natural history of Parkinson’s disease in LRRK2 G2019S carriers

    M. Kmiecik, D. Coker, K. Heilbron, S. Aslibekyan, J. Shelton, P. Cannon, L. Norcliffe-Kaufmann (Sunnyvale, USA)

    Objective: To document differences between the evolution of self-reported symptoms and prodromal markers in LRRK2 G2019S carriers and non-carriers with and without Parkinson’s Disease (PD).…
  • « Previous Page
  • 1
  • …
  • 186
  • 187
  • 188
  • 189
  • 190
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley